Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss

SHEFFIELD, England, May 20, 2019 /PRNewswire/ — Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, announced today that it successfully secured £1.4 million in seed funding. The financing, which was co-led by Boehringer Ingelheim Venture …

Source: https://www.prnewswire.com:443/news-releases/rinri-therapeutics-secures-1-4-million-seed-funding-to-advance-its-novel-regenerative-cell-therapy-to-treat-sensorineural-hearing-loss-300852863.html